Introduction: The global Neurodegenerative Disease Market is on the cusp of significant expansion, driven by the rising prevalence of neurodegenerative diseases such as Parkinson’s, multiple sclerosis, and Alzheimer’s disease. According to a recent study by MarketDigits, the market is projected to reach USD 69.8 billion by 2030, growing at a robust CAGR of 6.2% during…
Introduction: Neurodex is pleased to announce its participation in the upcoming 2nd Annual Meeting hosted by the American Association of Extracellular Vesicles (AAEV). Set against the picturesque backdrop of Boston, MA, this event promises to gather esteemed experts in extracellular vesicle research. Neurodex is gearing up to share its latest insights into the study of…
We are delighted to announce that Dr. Erez Eitan, Chief Scientific Officer of NeuroDex, will speak at the upcoming International Society for Extracellular Vesicles (ISEV) Workshop titled “EV-based Biomarkers: Commercialization and Clinical Implementation.” Scheduled to take place in the picturesque city of Aalborg, Denmark, from October 12th to 14th, 2023, this workshop is set to…